Biological and Medical Imaging Reagents: Global Markets

Description

List of Tables

The global market for biological and medical imaging reagents is estimated to grow from $26.6 billion in 2025 and forecast to reach $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

The North American market for biological and medical imaging reagents is estimated to grow from $11.3 billion in 2025 and forecast to reach $17.4 billion by the end of 2030, at a CAGR of 9.0% from 2025 to 2030.

The Asia-Pacific market for biological and medical imaging reagents is estimated to grow from $5.5 billion in 2025 and forecast to reach $8.6 billion by the end of 2030, at a CAGR of 9.8% from 2025 to 2030.

Report Scope

The report provides an overview of the global biological and medical imaging reagent market and analyzes market trends. It includes global revenue ($ millions) using 2024 as the base year, and the forecast from 2025 through 2030. The market is segmented based on type, modality, technology, application end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on major countries in these regions.

The report focuses on the significant driving trends and emerging technologies that influence the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global biological and medical imaging reagent companies. It also has a dedicated section of company profiles covering the profiles of leading companies in the market.

Report Includes

109 data tables and 68 additional tables
An overview of the global market for biological and medical imaging reagents
Analyses of the global market trends, with data from 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
Evaluation of the current market size and revenue growth prospects specific to the biologic and medical imaging reagents, accompanied by a market share analysis by product type, modality, technology, application, end use, and region
A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods, and analysis of current and future demand in the global biologic and medical imaging reagents industry, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
A relevant patent analysis with emphasis on emerging technologies and new developments
A discussion on ESG challenges and practices of the industry
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
Company profiles of the leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG and Becton, Dickinson and Co. (BD)

Product Code: HLC040F

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Forces Driving Industry Growth
Porter's Five Forces Analysis
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low to Moderate)
Industry Competition (High)
Macroeconomic Factors Analysis
Demand for Theranostics
Image-based Invasive and Noninvasive Procedures
Prevalence of Chronic Diseases and Rising Investments
Drug Discovery and Other R&D Activities
Development of Multifunctional Reagent Capabilities
Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
VC Investment
Impact of U.S. Tariff

Chapter 3 Market Dynamics

Overview
Market Drivers
Increasing Investments in R&D
Growing Prevalence of Chronic Diseases
Rising Adoption of Theranostics and Personalized Medicine
Replacement of Toxic Reagents with Safer Alternatives
Market Restraints
High Development and Commercialization Costs
Regulatory and Reimbursement Challenges
Market Opportunities
Integration of AI in Biologics R&D and Medical Imaging Reagents
Emergence of Multifunctional Imaging Reagents
Market Challenges
Safety Concerns
Short Shelf Life and Stability Issues

Chapter 4 Regulatory Landscape

Regulatory Approval Process, by Select Country/Region
U.S.
European Union
Asia-Pacific

Chapter 5 Emerging Technologies and Developments

Key Takeaways
Nanoparticles
Next-Generation Imaging Reagents for Single-Cell and Proteomic Applications
AI and ML in Biological and Medical Imaging Reagents
Innovative Lateral Flow Assays Enhanced by NIR Technology
Fluorochromes and Hybrid Targeting Platforms
Emerging Radiotracers Enhancing Diagnostic Accuracy in Oncology
Patent Analysis
Key Findings

Chapter 6 Market Segment Analysis

Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Contrast Reagents
Radioactive Reagents
Optical Reagents
Market Analysis by Modality
Key Takeaways
Optical Imaging Reagents
X-ray/CT Reagents
Nuclear Imaging Reagents
MRI Imaging Reagents
Multimodal Imaging Reagents
Ultrasound Imaging Reagents
Market Analysis by Technology
Key Takeaways
Quantum Dots
Radiopharmaceuticals
Fluorescent Proteins
Fluorescent Dyes and Probes
Nanoparticles
Market Analysis by Application
Key Takeaways
In Vivo Imaging Reagents
In Vitro Imaging Reagents
Market Analysis by End Use
Key Takeaways
Diagnostics
R&D
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Global Market Shares of Leading Companies
Key Developments and Strategies
Partnerships and Collaborations
Acquisitions
Business Expansions
Product Launches and FDA Approvals

Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective

Introduction to ESG
Steps Toward Sustainable Use of Biologics and Medical Imaging Reagents
Major Manufacturers: ESG Efforts
ESG Risk Ratings
Concluding Remarks from BCC

Chapter 9 Appendix

Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG.
BAYER AG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GE HEALTHCARE
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Few Emerging Start-ups/Market Disruptors

Product Code: HLC040F

List of Tables

Summary Table : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
Table 1 : Biological Imaging Reagents: Forces Driving Growth
Table 2 : Porter's Five Forces: Rating Scale
Table 3 : Current and Future Invasive and Noninvasive Imaging Technologies
Table 4 : Life Cycle Stage of Biological Imaging Reagents
Table 5 : Pharmaceutical R&D Expenditure in Selected Countries, 2023
Table 6 : Incidence and Mortality Rates of Cancer Across Regions, 2022
Table 7 : Nanoparticles in Imaging Applications
Table 8 : Select Published Patents on Biological and Medical Imaging Reagents, May 2025
Table 9 : Global Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 10 : Global Market for Contrast Reagents, by Region, Through 2030
Table 11 : Global Market for Radioactive Reagents, by Region, Through 2030
Table 12 : Global Market for Optical Reagents, by Region, Through 2030
Table 13 : Global Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 14 : Global Market for Optical Imaging Reagents, by Region, Through 2030
Table 15 : Global Market for X-ray/CT Imaging Reagents, by Region, Through 2030
Table 16 : Global Market for Nuclear Imaging Reagents, by Region, Through 2030
Table 17 : Key Brands of Gd-Based Contrast Reagents Worldwide
Table 18 : Global Market for MRI Imaging Reagents, by Region, Through 2030
Table 19 : Global Market for Multimodal Imaging Reagents, by Region, Through 2030
Table 20 : Global Market for Ultrasound Imaging Reagents, by Region, Through 2030
Table 21 : Global Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 22 : Biological Imaging Applications of QDs
Table 23 : Global Market for QDs Technology-based Imaging Reagents, by Region, Through 2030
Table 24 : Global Market for Radiopharmaceuticals Technology-based Imaging Reagents, by Region, Through 2030
Table 25 : Types of FPs
Table 26 : Global Market for FPs Technology-based Imaging Reagents, by Region, Through 2030
Table 27 : Fluorescent Dyes and Probes
Table 28 : Global Market for Fluorescent Dyes and Probes Technology-based Imaging Reagents, by Region, Through 2030
Table 29 : Global Market for Nanoparticle Technology-based Imaging Reagents, by Region, Through 2030
Table 30 : Global Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 31 : Biological Imaging Reagents Applications
Table 32 : Global Market for In Vivo Imaging Reagents, by Region, Through 2030
Table 33 : Significance of Medical Imaging Reagents to the Life Sciences and Medical Industries
Table 34 : Global Market for In Vitro Imaging Reagents, by Region, Through 2030
Table 35 : Global Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 36 : Global Market for Diagnostics Imaging Reagents, by Region, Through 2030
Table 37 : Global Market for R&D Imaging Reagents, by Region, Through 2030
Table 38 : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
Table 39 : North American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 40 : North American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 41 : North American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 42 : North American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 43 : North American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 44 : North American Market for Biological and Medical Imaging Reagents, by Country, Through 2030
Table 45 : U.S. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 46 : U.S. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 47 : U.S. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 48 : Canadian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 49 : Canadian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 50 : Canadian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 51 : Mexican Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 52 : Mexican Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 53 : Mexican Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 54 : European Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 55 : European Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 56 : European Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 57 : European Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 58 : European Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 59 : European Market for Biological and Medical Imaging Reagents, by Country, Through 2030
Table 60 : U.K. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 61 : U.K. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 62 : U.K. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 63 : French Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 64 : French Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 65 : French Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 66 : Italian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 67 : Italian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 68 : Italian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 69 : German Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 70 : German Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 71 : German Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 72 : Spanish Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 73 : Spanish Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 74 : Spanish Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 75 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 76 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 77 : Rest of Europe Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 78 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 79 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 80 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 81 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 82 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 83 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Country, Through 2030
Table 84 : Chinese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 85 : Chinese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 86 : Chinese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 87 : Indian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 88 : Indian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 89 : Indian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 90 : Japanese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 91 : Japanese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 92 : Japanese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 93 : Australian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 94 : Australian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 95 : Australian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 96 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 97 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 98 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 99 : South American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 100 : South American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 101 : South American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 102 : South American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 103 : South American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 104 : MEA Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
Table 105 : MEA Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
Table 106 : MEA Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
Table 107 : MEA Market for Biological and Medical Imaging Reagents, by Application, Through 2030
Table 108 : MEA Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
Table 109 : Leading Manufacturers in the Biological and Medical Imaging Reagent Market, 2024
Table 110 : Collaborations and Partnerships: Biological and Medical Imaging Reagents Market, 2022-2025
Table 111 : Acquisition: Biological and Medical Imaging Reagents Market, 2022-2025
Table 112 : Business Expansion Activities: Biological and Medical Imaging Reagents Market, 2023-2025
Table 113 : Product Launches and FDA Approval Activities: Biological and Medical Imaging Reagents Market, 2022-2025
Table 114 : Examples of Current Imaging Agents and Their Potential Concerns
Table 115 : ESG Highlights, by Major Players, 2024
Table 116 : ESG Risk Rankings for Biological and Medical Imaging Reagents Market, by Manufacturing Companies, 2024
Table 117 : Abbreviations Used in This Report
Table 118 : Report Information Sources
Table 119 : Agilent Technologies Inc.: Company Snapshot
Table 120 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 121 : Agilent Technologies Inc.: Product Portfolio
Table 122 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
Table 123 : Altona Diagnostic GmbH.: Company Snapshot
Table 124 : Altona Diagnostic GmbH.: Product Portfolio
Table 125 : Altona Diagnostic GmbH: News/Key Developments, 2022-2025
Table 126 : Analytik Jena GmbH+Co. KG: Company Snapshot
Table 127 : Analytik Jena GmbH+Co. KG: Product Portfolio
Table 128 : Analytik Jena GmbH+Co. KG: News/Key Developments, 2023 and 2024
Table 129 : Bayer AG: Company Snapshot
Table 130 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 131 : Bayer AG: Product Portfolio
Table 132 : Bayer AG: News/Key Developments, 2024 and 2025
Table 133 : BD: Company Snapshot
Table 134 : BD: Financial Performance, FY 2023 and 2024
Table 135 : BD: Product Portfolio
Table 136 : BD: News/Key Developments, 2022-2024
Table 137 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 138 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 139 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 140 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2025
Table 141 : Danaher Corp.: Company Snapshot
Table 142 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 143 : Danaher Corp.: Product Portfolio
Table 144 : Danaher Corp.: News/Key Developments, 2021-2023
Table 145 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 146 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 147 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 148 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023 and 2024
Table 149 : GE HealthCare: Company Snapshot
Table 150 : GE HealthCare: Financial Performance, FY 2023 and 2024
Table 151 : GE HealthCare: Product Portfolio
Table 152 : GE HealthCare: News/Key Developments, 2024 and 2025
Table 153 : Merck KGaA: Company Snapshot
Table 154 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 155 : Merck KGaA.: Product Portfolio
Table 156 : Merck KGaA: News/Key Developments, 2022-2025
Table 157 : Promega Corp.: Company Snapshot
Table 158 : Promega Corp.: Product Portfolio
Table 159 : Promega Corp.: News/Key Developments, 2023-2025
Table 160 : Qiagen: Company Snapshot
Table 161 : Qiagen: Financial Performance, FY 2023 and 2024
Table 162 : Qiagen: Product Portfolio
Table 163 : Qiagen: News/Key Developments, 2023-2025
Table 164 : Revvity: Company Snapshot
Table 165 : Revvity: Financial Performance, FY 2023 and 2024
Table 166 : Revvity: Product Portfolio
Table 167 : Revvity: News/Key Developments, 2023-2025
Table 168 : Siemens Healthineers AG: Company Snapshot
Table 169 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 170 : Siemens Healthineers AG: Product Portfolio
Table 171 : Siemens Healthineers AG: Key Developments, 2022-2024
Table 172 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 173 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 174 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 175 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
Table 176 : List of a Few Emerging Startups/Market Disruptors

List of Figures

Summary Figure : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
Figure 1 : Factors Impacting the Growth of the Biological Imaging Reagent Market, 2024 and 2030
Figure 2 : Global Pharmaceutical R&D Spending, by Select Country/Region, 2010-2022
Figure 3 : Market Dynamics of Biological and Medical Imaging Reagents
Figure 4 : Personalized Medicines' Contribution to Total FDA Approvals, 2015-2023
Figure 5 : Number of Patents Documented on Biological and Medical Imaging Reagents, by Leading Applicants, January 2024-May 2024
Figure 6 : Patent Shares on Biological and Medical Imaging Reagents, by Jurisdiction, January 2024-May 2025
Figure 7 : Patent Shares on Biological and Medical Imaging Reagents, by Type, January 2024-May 2025
Figure 8 : Global Market Shares of Biological and Medical Imaging Reagents, by Product Type, 2024
Figure 9 : Global Market Shares of Biological and Medical Imaging Reagents, by Modality, 2024
Figure 10 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
Figure 11 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
Figure 12 : Global Market Shares of Biological and Medical Imaging Reagents, by End Use, 2024
Figure 13 : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
Figure 14 : Company Share Analysis of Global Biological and Medical Imaging Reagent Market, 2024
Figure 15 : 3C Guidelines for the Handling and Design and of Medical Imaging Agents To Reduce the Pollution and Facilitate Ecologically Friendly Solutions
Figure 16 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 17 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 18 : Bayer AG: Revenue Share, by Business Unit, FY 2024
Figure 19 : Bayer AG: Revenue Share, by Country/Region, FY 2024
Figure 20 : BD: Revenue Share, by Business Unit, FY 2024
Figure 21 : BD: Revenue Share, by Country/Region, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 28 : GE HealthCare: Revenue Share, by Business Unit, FY 2024
Figure 29 : GE HealthCare: Revenue Share, by Country/Region, FY 2024
Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
Figure 32 : Qiagen: Revenue Share, by Business Unit, FY 2024
Figure 33 : Qiagen: Revenue Share, by Country/Region, FY 2024
Figure 34 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 35 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 36 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024
Figure 37 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024
Figure 38 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

Biological and Medical Imaging Reagents: Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segment Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective

Chapter 9 Appendix

List of Tables

List of Figures